• Nie Znaleziono Wyników

The Voice of the Editor-in-Chief

N/A
N/A
Protected

Academic year: 2022

Share "The Voice of the Editor-in-Chief"

Copied!
2
0
0
Pokaż więcej ( Stron)

Pełen tekst

(1)

1

The Voice of the Editor-in-Chief

The end of the year makes us reflect on all aspects of everyday life and review accomplishments and les- sons learned. First, I would like to thank you for the active participation in creating “Clinical Diabetology”

by submitting many interesting papers. Thanks to your efforts, our journal is indexed in the Scopus database and currently also in the Web of Science, which is an important starting point for its further development.

Moreover, “Clinical Diabetology” includes more and more original and review articles sent by foreign authors, which significantly broadens our view on diabetes care and improves the rank of our journal.

Offering you the last issue of “Clinical Diabeto- logy” in 2018, I would like to draw your attention to an article referring to diabetes care for children and adolescents in Poland. The authors point to significant

differences in the frequency, causes and duration of hospitalization of children with diabetes in different regions of Poland, which implies the need to ensure uniform access to specialist medical care as well as to increase public awareness about diabetes symp- toms in order to avoid hospitalization related with ketoacidosis in patients with newly diagnosed type 1 diabetes. Moreover, it is worth paying attention to the case report discussing iatrogenic hypoglycemia, which significantly widens the standard perception of this phenomenon, as well as an article about new developments in the pharmaceutical industry presen- ting new rapid-acting insulin analog.

I wish you a happy New Year 2019 and encourage you for further cooperation in creating “Clinical Dia- betology”

Editor-in-Chief

Prof. Janusz Gumprecht

Dear Colleagues,

(2)

Cytaty

Powiązane dokumenty

Data comparison analysis presented by the National Health Fund (NHF) and the Central Statistical Office (CSO) regarding frequency and causes of hospitalization of the elderly

Key words: tuberculosis, epidemiology of tuberculosis, differences in the notification of tuberculosis in various parts of Poland, indicators of wealth, social status, results

Professor Janusz Gumprecht has excellently developed the journal — it appears regularly, contains more and more papers from outside Poland, is included in the Web of Science

Just before the publication of this issue of “Cli- nical Diabetology”, the largest diabetes meeting in the world — 79 th Scientific Sessions of the American Diabetes

Although more than 3,500 years have passed since the first description of the symptoms of diabetes in the Egyptian papyrus dated to around 1550 BC, diabetes is still

Another challenge is effective and safe use of antidiabetic drugs to minimize side effects, improve adherence, increase the acceptance of the disease and reduce the risk

At the beginning of October, annual meeting of European Association for the Study of Diabetes (EASD) will be held in Berlin, and one of the most awaited events during this

Among papers included in this issue of “Clinical Diabetology”, it is worth paying attention to a multi- centre study conducted in 2013–2017 in women with type 1 diabetes who,

As the practical management of patients with diabetes should be based primarily on knowledge derived from Evidence Based Medicine (EBM), the reference to the EBM

I would like to draw your attention to the problem of diabetes care quality discussed by researchers from Libya, an interesting case report of the use of hydroxychloroquine in type

Many interesting reports presented during the Congress addressed, among others, epidemiology, new possibilities of molecular biology, measurable effects of translating basic

Following the publication of the results of already completed Cardiovascular Outcome Trials (CVOTs) on new molecules used in the treatment of diabetes, there is no doubt that

In the InTandem3 study (Study to Evaluate the Safety of So- tagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycaemic Control With Insulin Therapy Alone) with

In addition to attending the scientific meetings, I also encourage you to read the latest issue of the “Clinical Diabetology”, where, among a number of interesting articles, I would

Considering the above, I would like to draw your attention to two of many interesting articles published in the last issue of Clinical Diabetology: the paper presenting

In accordance with other diabetic organizations (the American Diabetes Association — ADA, the National Institute for Health and Care Excellence — NICE), glycaemic goals has

Here, it should be mentioned that also the LEADER trial, that assessed cardiovascular safety of one of GLP-1 agonists, liraglutide, in the population of type 2 diabetes

Despite recent advances in medicine, introduction of new hypoglycaemic drugs and the fact that more than 3.500 years have passed since the earliest known record of diabetes

The conference brought together a group of distinguished lecturers and almost 500 participants — physicians dealing in their everyday practice with carbohydrate

At the same time, we intend to continue the educational function of the journal and we do not want to hinder the access to its content for the readers; therefore, we decided

This change is a result of systematic de- velopment of our journal aiming at further increasing its presence and importance on the international arena and striving to

Przekazywał nam też hoj- nie swoje wiadomości, choć byliśmy w wieku, kiedy na ogół nie docenia się wielu skarbów pchających się w ręce.. Na szczęście zapamiętałam zdradzone

„Rodzina w systemie wsparcia społecznego i pomocy osobom z problemem alkoholowym”, zorganizowana przez Pracownię Pedagogiki Specjalnej, w ramach realizowanego